Alvin Coda, MD
Dermatology · la Jolla, CANPI 1588989487
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $101,139 of the $158,932 with a category attached, or 63.6%. 38 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 30.0% of the total. 2025 is the largest year on record at $67,119, 3.2 times the $20,970 reported in 2019. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 943 payments — averaging $168.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$48K
- UCB, Inc.$35K
- Pfizer$31K
- Galderma Laboratories, L.p.$11K
- Sanofi$9K
- LEO Pharma Inc.$6K
- plus $19K from 32 others
What the payments were for
- Consulting fees$29,26118%
- Speaking & faculty fees$101,13964%
- Travel & lodging$8,5715%
- Food & beverage$18,79512%
- Education$1,1671%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 91 | $47,633 |
| UCB, Inc. | 65 | $34,913 |
| Pfizer | 96 | $31,411 |
| Galderma Laboratories, L.p. | 38 | $10,712 |
| Sanofi | 64 | $9,144 |
| LEO Pharma Inc. | 41 | $5,794 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 16 | $5,517 |
| Incyte Corporation | 34 | $3,434 |
| Johnson & Johnson | 120 | $1,987 |
| AbbVie | 101 | $1,763 |
| Lilly USA, LLC | 38 | $948 |
| E.r. Squibb & Sons, L.L.C. | 14 | $934 |
| Regeneron Healthcare Solutions, Inc. | 36 | $923 |
| Novartis | 27 | $665 |
| Dermavant Sciences, Inc. | 53 | $617 |
| Amgen | 32 | $584 |
| Arcutis Biotherapeutics, Inc. | 22 | $447 |
| Sanofi-aventis U.S. LLC | 5 | $259 |
| Avita Medical Americas, LLC | 1 | $250 |
| Boehringer Ingelheim | 8 | $186 |
| Almirall LLC | 6 | $110 |
| Bristol Myers Squibb | 5 | $104 |
| Verrica Pharmaceuticals Inc. | 4 | $84 |
| Dermira, Inc. | 4 | $68 |
| Smith+Nephew | 1 | $63 |
| VYNE Pharmaceuticals Inc. | 2 | $45 |
| Integra Lifesciences Corporation | 2 | $44 |
| Aclaris Therapeutics, Inc. | 2 | $43 |
| Convatec Inc. | 2 | $38 |
| Prugen, Inc. Pharmaceuticals | 3 | $38 |
| Organon | 3 | $36 |
| Chiesi USA, Inc. | 1 | $26 |
| Hill Dermaceuticals, Inc. | 1 | $25 |
| Kerecis Limited | 1 | $21 |
| Sensus Healthcare, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Mission Pharmacal Company | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$158,932 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 42 | $197,127 |
| Taltz AutoinjectorIxekizumab | 11 | $73,951 |
| Fluorouracil | 218 | $14,095 |
| Clobetasol Propionate | 183 | $10,764 |
| Acitretin | 35 | $6,949 |
| Tacrolimus | 19 | $2,056 |
| ValacyclovirValacyclovir Hcl | 39 | $1,826 |
| Ketoconazole | 137 | $1,661 |
| Minoxidil | 91 | $1,646 |
| Tretinoin | 15 | $1,357 |
| Imiquimod | 60 | $1,340 |
| Fluconazole | 50 | $1,126 |
| Clindamycin Phosphate | 36 | $724 |
| Gabapentin | 38 | $711 |
| Doxycycline Monohydrate | 48 | $658 |
Paid to pharmacies, not to this prescriber.
Other dermatology in la Jolla
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.